+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Small Cell Lung Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Small Cell Lung Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030 - Product Thumbnail Image

GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030

  • Report
  • December 2024
  • 840 Pages
  • Middle East
From
Gout Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Gout Disease Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 473 Pages
  • Global
From
Psoriatic Arthritis Treatment - Global Strategic Business Report - Product Thumbnail Image

Psoriatic Arthritis Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 452 Pages
  • Global
From
Ankylosing Spondylitis - Global Strategic Business Report 2026 - Product Thumbnail Image

Ankylosing Spondylitis - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 271 Pages
  • Global
From
Skin Cancer Dermatology Market - Global Forecast 2026-2032 - Product Thumbnail Image

Skin Cancer Dermatology Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 197 Pages
  • Global
From
From
Pediatric Neuroblastoma Treatment Market Report 2026 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Anemia Drugs - Global Strategic Business Report 2026 - Product Thumbnail Image

Anemia Drugs - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 387 Pages
  • Global
From
From
From
Bleeding Disorder Drugs - Global Strategic Business Report - Product Thumbnail Image

Bleeding Disorder Drugs - Global Strategic Business Report

  • Report
  • November 2026
  • 488 Pages
  • Global
From
Hypercalcemia Treatment - Global Strategic Business Report 2026 - Product Thumbnail Image

Hypercalcemia Treatment - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 179 Pages
  • Global
From
From
From
Loading Indicator